Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Core Points - Akebia Therapeutics, Inc. granted options to purchase 130,763 shares of common stock to seven newly-hired employees as an inducement for employment [1][2] - The exercise price of the options is set at $2.24 per share, matching the closing price on the grant date [2] - The stock options will vest over four years, with 25% vesting on the first anniversary and the remaining 75% vesting quarterly, contingent on continued service [2] Company Overview - Akebia Therapeutics is a biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, founded in 2007 and headquartered in Cambridge, Massachusetts [3]